SYRE icon

Spyre Therapeutics

55 hedge funds and large institutions have $22.6M invested in Spyre Therapeutics in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
-11
Holders Change %
-16.67%
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
11
Reduced
14
Closed
15
Calls
$8K
Puts
Net Calls
+$8K
Net Calls Change
-$15K
Name Holding Trade Value Shares
Change
Shares
Change %
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$828 -$1.95K -148 -70%
Dimensional Fund Advisors
52
Dimensional Fund Advisors
Texas
-$255K -20,253 Closed
D.E. Shaw & Co
53
D.E. Shaw & Co
New York
-$241K -19,056 Closed
LPC
54
Lion Point Capital
New York
-$1.43M -12,000 Closed
E
55
Ergoteles
New York
-$74K -5,888 Closed
UBS Group
56
UBS Group
Switzerland
-$39K -3,072 Closed
Susquehanna International Group
57
Susquehanna International Group
Pennsylvania
-$33K -2,608 Closed
BCM
58
Bridgeway Capital Management
Texas
-$25K -1,946 Closed
VF
59
Virtu Financial
New York
-$16K -1,246 Closed
SG Americas Securities
60
SG Americas Securities
New York
-$9K -713 Closed
SSA
61
Schonfeld Strategic Advisors
New York
-$5K -404 Closed
Legal & General Group
62
Legal & General Group
United Kingdom
-$2K -131 Closed
Fidelity Investments
63
Fidelity Investments
Massachusetts
-$1K -60 Closed